WO2003025005A3 - Nouveaux polypeptides purifies impliques dans le traitement des proteines - Google Patents

Nouveaux polypeptides purifies impliques dans le traitement des proteines Download PDF

Info

Publication number
WO2003025005A3
WO2003025005A3 PCT/CA2002/001426 CA0201426W WO03025005A3 WO 2003025005 A3 WO2003025005 A3 WO 2003025005A3 CA 0201426 W CA0201426 W CA 0201426W WO 03025005 A3 WO03025005 A3 WO 03025005A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein processing
purified bacterial
polypeptides involved
bacterial polypeptides
involved
Prior art date
Application number
PCT/CA2002/001426
Other languages
English (en)
Other versions
WO2003025005A2 (fr
Inventor
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Muhammad Zahoor Alam
Donald Awrey
Bryan Beattie
Veronica Canadien
Megan Domagala
Dhushy Kanagarajah
Qin Li
Kamran Mansoury
Sasha Necakov
Kathleen Nethery
Ivy Ng
Benjamin Pinder
Bay Sheldrick
Francois Vallee
Cristina Viola
Olga Wrezel
Original Assignee
Affinium Pharm Inc
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Muhammad Zahoor Alam
Donald Awrey
Bryan Beattie
Veronica Canadien
Megan Domagala
Dhushy Kanagarajah
Qin Li
Kamran Mansoury
Sasha Necakov
Kathleen Nethery
Ivy Ng
Benjamin Pinder
Bay Sheldrick
Francois Vallee
Cristina Viola
Olga Wrezel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharm Inc, Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Zahoor Alam, Donald Awrey, Bryan Beattie, Veronica Canadien, Megan Domagala, Dhushy Kanagarajah, Qin Li, Kamran Mansoury, Sasha Necakov, Kathleen Nethery, Ivy Ng, Benjamin Pinder, Bay Sheldrick, Francois Vallee, Cristina Viola, Olga Wrezel filed Critical Affinium Pharm Inc
Priority to AU2002328222A priority Critical patent/AU2002328222A1/en
Publication of WO2003025005A2 publication Critical patent/WO2003025005A2/fr
Publication of WO2003025005A3 publication Critical patent/WO2003025005A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des cibles polypeptides pour des bactéries pathogènes. L'invention concerne également les caractéristiques biochimiques et biophysiques de ces polypeptides.
PCT/CA2002/001426 2001-09-21 2002-09-20 Nouveaux polypeptides purifies impliques dans le traitement des proteines WO2003025005A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002328222A AU2002328222A1 (en) 2001-09-21 2002-09-20 Purified bacterial polypeptides involved in protein processing

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US32413901P 2001-09-21 2001-09-21
US32413501P 2001-09-21 2001-09-21
US60/324,135 2001-09-21
US60/324,139 2001-09-21
US32533301P 2001-09-27 2001-09-27
US60/325,333 2001-09-27
US32583601P 2001-09-28 2001-09-28
US60/325,836 2001-09-28
US33823501P 2001-10-25 2001-10-25
US34375801P 2001-10-25 2001-10-25
US60/343,758 2001-10-25
US60/338,235 2001-10-25
US34053101P 2001-10-26 2001-10-26
US60/340,531 2001-10-26
US34094501P 2001-10-30 2001-10-30
US60/340,945 2001-10-30
US33328101P 2001-11-06 2001-11-06
US60/333,281 2001-11-06
US39992602P 2002-07-31 2002-07-31
US60/399,926 2002-07-31

Publications (2)

Publication Number Publication Date
WO2003025005A2 WO2003025005A2 (fr) 2003-03-27
WO2003025005A3 true WO2003025005A3 (fr) 2004-03-11

Family

ID=27581235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2002/001426 WO2003025005A2 (fr) 2001-09-21 2002-09-20 Nouveaux polypeptides purifies impliques dans le traitement des proteines

Country Status (2)

Country Link
AU (1) AU2002328222A1 (fr)
WO (1) WO2003025005A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116218711B (zh) * 2022-12-21 2024-02-06 陕西省微生物研究所 一株乳酸乳球菌pz1及其在制备富硒低聚肽中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (fr) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynucléotides et séquences de Staphylococcus aureus
WO1999018187A1 (fr) * 1997-10-03 1999-04-15 Smithkline Beecham Corporation POLYPEPTIDES 'clpL'

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (fr) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynucléotides et séquences de Staphylococcus aureus
WO1999018187A1 (fr) * 1997-10-03 1999-04-15 Smithkline Beecham Corporation POLYPEPTIDES 'clpL'

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOTRA LAKSHMI P ET AL: "From genes to sequences to antibiotics: Prospects for future developments from microbial genomics.", MICROBES AND INFECTION, vol. 2, no. 6, May 2000 (2000-05-01), pages 651 - 658, XP002248204, ISSN: 1286-4579 *
ROSAMOND J ET AL: "Harnessing the power of the genome in the search for new antibiotics", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 287, no. 5460, 17 March 2000 (2000-03-17), pages 1973 - 1976, XP002226396, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
WO2003025005A2 (fr) 2003-03-27
AU2002328222A1 (en) 2003-04-01

Similar Documents

Publication Publication Date Title
WO2004041854A3 (fr) Nouveaux polypeptides bacteriens essentiels
AUPP589598A0 (en) Novel peptides
WO2003087353A3 (fr) Nouveaux polypeptides purifies impliques dans la biogenese membranaire
WO2006028561A3 (fr) Nouveaux polypeptides fabi purifies issus de fransicella tularensis
AU2002349231A1 (en) Methylotrophic bacterium for the production of recombinant proteins and other products
WO2003025008A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement de proteines
WO2003025004A3 (fr) Polypeptides purifies intervenant dans le traitement d'acides nucleiques
WO2003025005A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des proteines
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
WO2003102190A3 (fr) Nouveaux polypeptides purifies responsables de la viabilite bacterienne
WO2003035858A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des acides nucleiques
WO2003083099A3 (fr) Nouveaux polypeptides purifies impliques dans la synthese et la modification des proteines
WO2003025006A3 (fr) Nouveaux polypeptides purifies impliques dans le metabolisme des cofacteurs
WO2003027139A3 (fr) Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire
WO2003087145A3 (fr) Nouveaux polypeptides purifies impliques dans la detection de densite cellulaire
WO2003025007A3 (fr) Nouveaux polypeptides purifies impliques dans la biosynthese membranaire
WO2003084986A3 (fr) Nouveaux polypeptides modifies impliques dans le metabolisme cellulaire
WO2004058809A3 (fr) Nouveaux polypeptides bacteriens essentiels
WO2004044189A3 (fr) Nouveaux polypeptides purifies jouant un role dans le metabolisme
WO2003045986A3 (fr) Nouveaux polypeptides purifies impliques dans le metabolisme general
WO2004042043A3 (fr) Structures cristallines de 3-epimerases bacteriennes de ribulose-phosphate
WO2003085103A3 (fr) Nouveaux polypeptides purifies impliques dans l'hydrolyse de nucleotides
WO2003097789A3 (fr) Nouveaux polypeptides purifies issus de pseudomonas aeruginosa
WO2003060067A3 (fr) Acides nucleiques et polypeptides p85-alpha, et procedes associes
WO2005005469A3 (fr) Nouveaux polypeptides purifies provenant du staphylocoque dore

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP